InvivoGen's product citations


InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Tri-DAP Trained immunity or tolerance: opposing functional programs induced in human ... 2014 Clin Vaccine Immunol. Ifrim D.C. et al. DOI: 10.1128/CVI.00688-13
ODN M362 - TLR9 ligand Inducible epithelial resistance protects mice against leukemia-associated pne... 2016 Blood. Leiva-Juárez M.M. et al. DOI: 10.1182/blood-2016-03-708511
Caspase-1 and Caspase-4 inhibitor HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications... 2016 J Neuroimmune Pharmacol. Mamik M.K. et al. DOI: 10.1007/s11481-016-9708-3
pSELECT HA-Tag Characterization of C-type lectins reveals an unexpectedly limited interactio... 2017 PLoS One. Walsh N.M. et al. DOI: 10.1371/journal.pone.0173866
HEK-Blue™ mTLR2 Structure-based programming of lymph-node targeting in molecular vaccines. 2014 Nature Liu H. et al. DOI: 10.1038/nature12978
ODN 1826 VacciGrade™ Self-assembling peptides epitopes as a novel platform for anti-cancer vaccina... 2017 Mol Pharm. Rad-Malekshahi M. et al. DOI: 10.1021/acs.molpharmaceut.6b01003
pFUSE-CHIg-mG1 Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus I... 2016 J Virol. Cowton V.M. et al. DOI: 10.1128/JVI.00685-16
Human TLR1-9 Agonist kit Anti-inflammatory effects of nicotinic acid in human monocytes are mediated b... 2012 Arterioscler Thromb Vasc Biol. Digby J.E. et al. DOI: 10.1161/ATVBAHA.111.241836
Gardiquimod™ TLR7 induces anergy in human CD4+ T cells. 2015 Nat Immunol. Dominguez-Villar M. et al. DOI: 10.1038/ni.3036
PGN-SA peptidoglycan preparation Genome-wide RNAi screening implicates the E3 ubiquitin ligase Sherpa in media... 2016 Sci Signal. Kanoh H. et al. DOI: 10.1126/scisignal.2005971
CLI-095 A systemic defect in Toll-like receptor 4 signaling increases lipopolysacchar... 2016 Am J Physiol Lung Cell Mol Physiol. Knobloch J. et al. DOI: 10.1152/ajplung.00367.2014
LPS-EK (LPS from E. coli K12) Mumps Virus SH protein inhibits NF-κB activation by interacting with TNFR1, I... 2017 J Virol. Franz S. et al. DOI: 10.1128/JVI.01037-17
TLR09-HA Short single-stranded DNA degradation products augment the activation of Toll... 2017 Nat Commun. Pohar J. et al. DOI: 10.1038/ncomms15363
CPPD Crystals The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type ... 2012 Immunity Lei Y. et al. DOI: 10.1016/j.immuni.2012.03.025
ODN 2006 (ODN 7909) Iron nanomedicines induce Toll-like receptor activation, cytokine production ... 2017 Biomaterials. Verhoef J.J. et al. DOI: 10.1016/j.biomaterials.2016.11.025
HEK-Blue™ hTLR4 MSRV envelope protein is a potent, endogenous and pathogenic agonist of human... 2016 J Neuroimmunol. Madeira A. et al. DOI: 10.1016/j.jneuroim.2015.12.006
ODN 4084-F Inflammatory cytokines break down intrinsic immunological tolerance of human ... 2014 J Immunol. Chiliveru S. et al. DOI: 10.4049/jimmunol.1302120
Anti-hCD20-hIgG3 A rheumatoid factor paradox: inhibition of rituximab effector function. 2013 Arthritis Res Ther. Jones JD. et al. 15(1):R20.
Alhydrogel® adjuvant 2% T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of... 2017 J Immunol. Middleton DR. et al. DOI: 10.4049/jimmunol.1700026
Plasmocin® - Mycoplasma Elimination Reagent Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Deliver... 2015 ACS Nano. Evans B.C. et al. DOI: 10.1021/acsnano.5b00491


Customer Service
& Technical Support
Contact us
Shopping cart is empty